ENTROPY NEURODYNAMICS LIMITED — Director's Dealing 2023

Jun 21, 2023

Appendix 3X Initial Director’s Interest Notice

Rule 3.19A.1

Appendix 3X

Initial Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity	Exopharm Limited
ABN	78 163 765 991

We (the entity) give ASX the following information under listing rule 3.19A.1 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Mark Davies
Date of appointment	22 June 2023

Part 1 - Director’s relevant interests in securities of which the director is the registered holder In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Number & class of securities

Nil

• See chapter 19 for defined terms.

Appendix 3X Page 1

11/3/2002

Appendix 3X Initial Director’s Interest Notice

Part 2 – Director’s relevant interests in securities of which the director is not the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Name of holder & nature of interest Note: Provide details of the circumstances giving rise to the relevant interest.	Number & class of Securities Nil

Part 3 – Director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	Non-Executive Director Equity Entitlement
Nature of interest	Subject to shareholder approval, allotment of 10,000,000 Unlisted Options as follows: • 5,000,000 Unlisted Options, exercisable at 1.5 cents, expiring 48 months from the date of allotment; • 2,500,000 Unlisted Options, exercisable at 2.0 cents, expiring 48 months from the date of allotment; and • 2,500,000 Unlisted Options, exercisable at 3.0 cents, expiring 48 months from the date of allotment.
Name of registered holder (if issued securities)	Mark Davies or his nominee
No. and class of securities to which interest relates	10,000,000 Unlisted Options

• See chapter 19 for defined terms.

Appendix 3X Page 2

11/3/2002